These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 12234649)

  • 1. Mental disorders in ecstasy users: a prospective-longitudinal investigation.
    Lieb R; Schuetz CG; Pfister H; von Sydow K; Wittchen H
    Drug Alcohol Depend; 2002 Oct; 68(2):195-207. PubMed ID: 12234649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use, abuse and dependence of ecstasy and related drugs in adolescents and young adults-a transient phenomenon? Results from a longitudinal community study.
    von Sydow K; Lieb R; Pfister H; Höfler M; Wittchen HU
    Drug Alcohol Depend; 2002 Apr; 66(2):147-59. PubMed ID: 11906802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-reported psychopathology among young, low-income, female ecstasy users.
    Wu ZH; Baillargeon JG; Berenson AB; Holzer CE
    J Addict Dis; 2008; 27(4):81-90. PubMed ID: 19042593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathways to ecstasy use in young adults: anxiety, depression or behavioural deviance?
    Alati R; Kinner SA; Hayatbakhsh MR; Mamun AA; Najman JM; Williams GM
    Drug Alcohol Depend; 2008 Jan; 92(1-3):108-15. PubMed ID: 17850992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Psychological aspects of MDMA (ecstasy) users].
    Varescon I
    Ann Med Interne (Paris); 2003 Nov; 154 Spec No 2():S81-5. PubMed ID: 14760230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation.
    Daumann J; Hensen G; Thimm B; Rezk M; Till B; Gouzoulis-Mayfrank E
    Psychopharmacology (Berl); 2004 May; 173(3-4):398-404. PubMed ID: 14722704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Past 12-month and lifetime comorbidity and poly-drug use of ecstasy users among young adults in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
    Keyes KM; Martins SS; Hasin DS
    Drug Alcohol Depend; 2008 Sep; 97(1-2):139-49. PubMed ID: 18524499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of ecstasy use in Australia: findings from a national household survey.
    Degenhardt L; Barker B; Topp L
    Addiction; 2004 Feb; 99(2):187-95. PubMed ID: 14756711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathways into ecstasy use: the role of prior cannabis use and ecstasy availability.
    Zimmermann P; Wittchen HU; Waszak F; Nocon A; Höfler M; Lieb R
    Drug Alcohol Depend; 2005 Sep; 79(3):331-41. PubMed ID: 15913921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the use of ecstasy and hallucinogens increasing? Results from a community study.
    Schuster P; Lieb R; Lamertz C; Wittchen HU
    Eur Addict Res; 1998 Mar; 4(1-2):75-82. PubMed ID: 9740820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The external validity of results derived from ecstasy users recruited using purposive sampling strategies.
    Topp L; Barker B; Degenhardt L
    Drug Alcohol Depend; 2004 Jan; 73(1):33-40. PubMed ID: 14687957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing ecstasy users and non-users in a population-based and co-twin control design across multiple traits.
    Vreeker A; Brunt TM; Treur JL; Willemsen G; Boomsma DI; Verweij KJH; Vink JM
    Addict Behav; 2020 Sep; 108():106421. PubMed ID: 32497976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Club drug use in Germany.
    Soellner R
    Subst Use Misuse; 2005; 40(9-10):1279-93. PubMed ID: 16048817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Longitudinal Study of Self-Reported Psychopathology in Beginning Ecstasy and Amphetamine Users: A Third Follow-up Evaluation.
    Wagner D; Sauder T; Koester P; Gouzoulis-Mayfrank E; Daumann J
    Subst Use Misuse; 2017 Oct; 52(12):1557-1564. PubMed ID: 28471316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems.
    Parrott AC; Milani RM; Parmar R; Turner JD
    Psychopharmacology (Berl); 2001 Dec; 159(1):77-82. PubMed ID: 11797073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ecstasy and new patterns of drug use: a normal population study.
    Pedersen W; Skrondal A
    Addiction; 1999 Nov; 94(11):1695-706. PubMed ID: 10892008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs.
    Halpern JH; Sherwood AR; Hudson JI; Gruber S; Kozin D; Pope HG
    Addiction; 2011 Apr; 106(4):777-86. PubMed ID: 21205042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Male and female ecstasy users: differences in patterns of use, sleep quality and mental health outcomes.
    Ogeil RP; Rajaratnam SM; Broadbear JH
    Drug Alcohol Depend; 2013 Sep; 132(1-2):223-30. PubMed ID: 23453259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polysubstance use and its correlates in adolescent ecstasy users in Taiwan.
    Yen CF; Hsu SY; Cheng CP
    Addict Behav; 2007 Oct; 32(10):2286-91. PubMed ID: 17314013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mental disorders in current and former heavy ecstasy (MDMA) users.
    Thomasius R; Petersen KU; Zapletalova P; Wartberg L; Zeichner D; Schmoldt A
    Addiction; 2005 Sep; 100(9):1310-9. PubMed ID: 16128720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.